 |
|
December 1, 1999
JAMA. 1999;282:2087-2088.
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is available only to physicians licensed in the United States, Canada, or Mexico.
Earning Credit and the CME Evaluation Form
To earn credit, read 3 of the articles listed below that are designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 1 month of the issue date. A certificate awarding 1 hour of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.
One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of JAMA. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
Statement of Educational Purpose
JAMA is a general medical journal. Its mission and educational purpose is to promote the science and art of medicine and the betterment of the public health. A flexible curriculum of article topics is developed annually by THE JOURNAL's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. To accommodate the diversity of practice types within JAMA's readership, the Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.
Readers of JAMA should be able to attain the following educational objectives: (1) select and read at least 3 articles in 1 issue to gain new medical information on topics of particular interest to them as physicians, (2) assess the articles' value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices. The educational objective for each CME article is given after the article title below.
CME Articles in This Issue of JAMA
The following articles in this issue may be read for CME credit:
Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study (SEE ARTICLE)
Educational Objective: To learn that intra-arterial prourokinase may improve early clinical outcome after ischemic stoke.
Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy (SEE ARTICLE)
Educational Objective: To compare life expectancy for people with and without major cardiovascular risk factors.
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset: The ATLANTIS Study (SEE ARTICLE)
Educational Objective: To learn the risks and benefits of treating stroke with rt-PA after 3 hours.
Dietary Sodium Intake and Subsequent Risk of Cardiovascular Disease in Overweight Adults (SEE ARTICLE)
Educational Objective: To understand the risks of high sodium intake for people who are overweight.
Hemodynamic Shear Stress and Its Role in Atherosclerosis (SEE ARTICLE)
Educational Objective: To understand the influence of shear stress on the development of focal atherosclerotic lesions.
Preventing Coronary Artery Disease by Lowering Cholesterol Levels: Fifty Years From Bench to Bedside (SEE ARTICLE)
Educational Objective: To understand how investigators learned that cardiovascular disease may be prevented by treating hypercholesterolemia.
An Evidence-Based Assessment of the NCEP Adult Treatment Panel II Guidelines (SEE ARTICLE)
Educational Objective: To understand an expert panel's assessment of current guidelines for the treatment of hypercholesterolemia.
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis (SEE ARTICLE)
Educational Objective: To review the clinical benefits of statin drug therapy.
Chlamydia pneumoniae and Atherosclerosis (SEE ARTICLE)
Educational Objective: To learn what is known about the relationship of Chlamydia pneumoniae and atherosclerotic lesions.
After reading 3 of these articles, complete the CME Evaluation Form.
RELATED ARTICLES
Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial
Anthony Furlan, Randall Higashida, Lawrence Wechsler, Michael Gent, Howard Rowley, Carlos Kase, Michael Pessin, Arvind Ahuja, Fred Callahan, Wayne M. Clark, Frank Silver, Frank Rivera, and for the PROACT Investigators
JAMA. 1999;282(21):2003-2011.
ABSTRACT
| FULL TEXT
Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy: Findings for 5 Large Cohorts of Young Adult and Middle-Aged Men and Women
Jeremiah Stamler, Rose Stamler, James D. Neaton, Deborah Wentworth, Martha L. Daviglus, Dan Garside, Alan R. Dyer, Kiang Liu, and Philip Greenland
JAMA. 1999;282(21):2012-2018.
ABSTRACT
| FULL TEXT
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset: The ATLANTIS Study: A Randomized Controlled Trial
Wayne M. Clark, Stanley Wissman, Gregory W. Albers, Jack H. Jhamandas, Kenneth P. Madden, Scott Hamilton, and for the ATLANTIS Study Investigators
JAMA. 1999;282(21):2019-2026.
ABSTRACT
| FULL TEXT
Dietary Sodium Intake and Subsequent Risk of Cardiovascular Disease in Overweight Adults
Jiang He, Lorraine G. Ogden, Suma Vupputuri, Lydia A. Bazzano, Catherine Loria, and Paul K. Whelton
JAMA. 1999;282(21):2027-2034.
ABSTRACT
| FULL TEXT
Hemodynamic Shear Stress and Its Role in Atherosclerosis
Adel M. Malek, Seth L. Alper, and Seigo Izumo
JAMA. 1999;282(21):2035-2042.
ABSTRACT
| FULL TEXT
Preventing Coronary Artery Disease by Lowering Cholesterol Levels: Fifty Years From Bench to Bedside
Daniel Steinberg and Antonio M. Gotto, Jr
JAMA. 1999;282(21):2043-2050.
ABSTRACT
| FULL TEXT
An Evidence-Based Assessment of the NCEP Adult Treatment Panel II Guidelines
Benjamin J. Ansell, Karol E. Watson, and Alan M. Fogelman
JAMA. 1999;282(21):2051-2057.
ABSTRACT
| FULL TEXT
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Sonia S. Anand and Salim Yusuf
JAMA. 1999;282(21):2058-2067.
ABSTRACT
| FULL TEXT
Chlamydia pneumoniae and Atherosclerosis
Allan Shor and James I. Phillips
JAMA. 1999;282(21):2071-2073.
EXTRACT
| FULL TEXT
|
